These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2048819)
61. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297 [TBL] [Abstract][Full Text] [Related]
62. Use of inhaled corticosteroids in patients with mild asthma. Lorentzson S; Boe J; Eriksson G; Persson G Thorax; 1990 Oct; 45(10):733-5. PubMed ID: 1978947 [TBL] [Abstract][Full Text] [Related]
63. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Henriksen JM; Dahl R Am Rev Respir Dis; 1983 Dec; 128(6):993-7. PubMed ID: 6359989 [TBL] [Abstract][Full Text] [Related]
65. Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide. du Toit JI; Anderson SD; Jenkins CR; Woolcock AJ; Rodwell LT Allergy Asthma Proc; 1997; 18(1):7-14. PubMed ID: 9066830 [TBL] [Abstract][Full Text] [Related]
66. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H; Orozco S; Allen A Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247 [TBL] [Abstract][Full Text] [Related]
67. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752 [TBL] [Abstract][Full Text] [Related]
68. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Watson A; Lim TK; Joyce H; Pride NB Chest; 1992 Feb; 101(2):350-5. PubMed ID: 1735253 [TBL] [Abstract][Full Text] [Related]
69. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Clark DJ; Grove A; Cargill RI; Lipworth BJ Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. Kerwin EM; Pearlman DS; de Guia T; Carlsson LG; Gillen M; Uryniak T; Simonson SG Curr Med Res Opin; 2008 May; 24(5):1497-510. PubMed ID: 18419878 [TBL] [Abstract][Full Text] [Related]
71. A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma. Youngchaiyud P; Permpikul C; Suthamsmai T; Wong E Allergy; 1995 Jan; 50(1):28-33. PubMed ID: 7741186 [TBL] [Abstract][Full Text] [Related]
72. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Clark DJ; Lipworth BJ Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246 [TBL] [Abstract][Full Text] [Related]
73. The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. De Baets FM; Goeteyn M; Kerrebijn KF Am Rev Respir Dis; 1990 Sep; 142(3):581-6. PubMed ID: 2389909 [TBL] [Abstract][Full Text] [Related]
74. Inhaled corticosteroid improves bronchial reactivity and decreases symptoms in patients with mitral stenosis. Cieslewicz G; Juszczyk G; Foremny J; Hamelmann E; Religa Z; Zembala M; Gelfand EW Chest; 1998 Oct; 114(4):1070-4. PubMed ID: 9792579 [TBL] [Abstract][Full Text] [Related]
75. [Budesonide in the treatment of mild asthma. A placebo-controlled multicenter study in general practice]. Damsbo N Ugeskr Laeger; 1994 Oct; 156(43):6384-8. PubMed ID: 7810015 [TBL] [Abstract][Full Text] [Related]
76. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989 [TBL] [Abstract][Full Text] [Related]
77. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Rabe KF; Pizzichini E; Ställberg B; Romero S; Balanzat AM; Atienza T; Lier PA; Jorup C Chest; 2006 Feb; 129(2):246-256. PubMed ID: 16478838 [TBL] [Abstract][Full Text] [Related]
78. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257 [TBL] [Abstract][Full Text] [Related]
79. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Burke C; Power CK; Norris A; Condez A; Schmekel B; Poulter LW Eur Respir J; 1992 Jan; 5(1):73-9. PubMed ID: 1577153 [TBL] [Abstract][Full Text] [Related]
80. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]